Vickie Y Jo

16PUBLICATIONS
78CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 09, 2025
Elraglusib, a Glycogen Synthase Kinase 3β Inhibitor, plus Chemotherapy with or without Immunotherapy in Patients with Recurrent, Metastatic Salivary Gland Carcinoma.

Glenn J Hanna, Nicole Scarfo, Kee-Young Shin

|Dec 23, 2024
A Prospective Trial of Biomarker-Guided Surveillance for HPV-Positive Oropharynx Cancer Using Plasma Tumor Tissue-Modified Viral HPV DNA.

Eleni M Rettig, Jonathan D Schoenfeld, Julianna Miller

|Dec 03, 2024
Duvelisib with Docetaxel for Patients with Anti-PD-1 Refractory, Recurrent, or Metastatic Head and Neck Squamous Cell Carcinoma.

Glenn J Hanna, L B Oakley, R Shi

|Sep 08, 2023
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer.

Giacomo Oliveira, Ann Marie Egloff, Alexander B Afeyan

|Jul 16, 2022
Molecular assessment of paratesticular rhabdomyomas demonstrates recurrent findings, including a novel H3C2 p.K37I mutation.

Andres M Acosta, Jesse K McKenney, Lynette M Sholl

|Apr 06, 2022
Secretory carcinoma of the salivary gland, a rare entity: An international multi-institutional study.

Austin B Wiles, Matthew Gabrielson, Zubair W Baloch

Pageof 3

Frequent Collaborators

5 joint publications

Jeffrey F Krane

3 joint publications

Glenn J Hanna

3 joint publications

Esther Diana Rossi

3 joint publications

Liron Pantanowitz